Presse medicale (Paris, France : 1983) · 2016
[Other therapeutic strategies].
Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Saba Ghassen, Nieto Isabel, Bation Rémy, Allaïli Najib, Bennabi Djamila, Moliere Fanny, Richieri Raphaëlle, Holtzmann Jérôme, Bubrovszky Maxime, Camus Vincent, Charpeaud Thomas, Courtet Philippe, Courvoisier Pierre, Haesebaert Frédéric, Doumy Olivier, El-Hage Wissam, Garnier Marion, d'Amato Thierry, Bougerol Thierry, Lançon Christophe, Haffen Emmanuel, Llorca Pierre-Michel, Vaiva Guillaume, Bellivier Frank, Leboyer Marion, Aouizerate Bruno
Аннотация
Non-selective and irreversible MAOI have become as third or fourth-line strategy for the management of treatment-resistant depression. Non-selective and irreversible MAOI requires careful monitoring of drug interactions and dietary restrictions. Nutritional supplements such as omega-3 have been found to produce beneficial effects in the management of treatment-resistant depression when administered in combination with the ongoing antidepressant treatment. The glutamate antagonist ketamine has been found to produce beneficial effects in the management of treatment-resistant depression while administered alone. Dopamine and/or norepinephrine agonists, such as methylphenidate, modafinil or pramipexole, have been found to produce beneficial effects in the management of treatment-resistant depression when administered in combination with the ongoing antidepressant treatment.
Предметные рубрики MeSH
Adrenergic alpha-AgonistsAntidepressive AgentsCentral Nervous System StimulantsDepressive DisorderDietary SupplementsDopamine AgonistsDouble-Blind MethodDrug InteractionsDrug ResistanceDrug Therapy, CombinationExcitatory Amino Acid AntagonistsFatty Acids, Omega-3Folic AcidFood-Drug InteractionsHumansKetamineMonoamine Oxidase InhibitorsRandomized Controlled Trials as TopicS-Adenosylmethionine